Market›Health Care›Pharmaceuticals›Pharmaceuticals
KNIGHT THERAPEUTICS

KHTRF

$5.52Apr 28, 2021 – Apr 27, 2026
Health CarePharmaceuticals$539M
MVM
+$539.3M
TD Variance
0.002

Every news event mapped to its market reaction — 48 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-03-11+11.5%newsSeeking AlphaEndo to sell International Pharmaceuticals business for $99 million
2024-11-07-9.6%earningsSeeking AlphaKnight Therapeutics reports Q3 results
2026-03-19+9.6%earningsMarketBeatKnight Therapeutics Q4 Earnings Call Highlights
2026-03-19+9.6%earningsGuruFocus.comKnight Therapeutics Inc (KHTRF) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ...
2026-03-19+9.6%newsSeeking AlphaKnight Therapeutics reports FY results
2026-03-19+9.6%earningsSeeking AlphaKnight Therapeutics Inc. (GUD:CA) Q4 2025 Earnings Call Transcript
2026-03-24+9.0%earningsMT NewswiresStifel Canada Reviews Knight Therapeutics "Solid" Q4
2026-03-23+8.6%newsMT NewswiresKnight Therapeutics Higher As Amends Its Normal Course Issuer Bid
2026-03-23+8.6%newsGlobeNewswireKnight Amends Normal Course Issuer Bid
2023-03-23-5.9%earningsSeeking AlphaKnight Therapeutics (KHTRF) Q4 2022 Earnings Call Transcript
2023-03-23-5.9%earningsSeeking AlphaKnight Therapeutics GAAP EPS of -C$0.13, revenue of C$81.66M; issues FY23 guidance
2025-11-06+4.7%earningsSeeking AlphaKnight Therapeutics Inc. (GUD:CA) Q3 2025 Earnings Call Transcript
2025-11-06+4.7%earningsSeeking AlphaKnight Therapeutics reports Q3 results
2023-05-11+4.2%earningsSeeking AlphaKnight Therapeutics reports Q1 earnings; updates FY23 outlook
2023-11-12+4.0%earningsSeeking AlphaKnight Therapeutics Inc. (KHTRF) Q3 2023 Earnings Call Transcript
2026-03-25+3.8%newsSimply Wall St.TSX Value Picks Knight Therapeutics And 2 Other Stocks Estimated Below Intrinsic Value
2026-03-27+3.6%legalGlobeNewswireKnight Therapeutics Inc. ranks on The Globe and Mail’s second annual Canada’s Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity
2025-05-11-3.3%earningsSeeking AlphaKnight Therapeutics Inc. (KHTRF) Q1 2025 Earnings Call Transcript
2024-03-21-3.1%earningsSeeking AlphaKnight Therapeutics Inc. (KHTRF) Q4 2023 Earnings Call Transcript
2024-03-21-3.1%earningsSeeking AlphaKnight Therapeutics GAAP EPS of -C$0.23, revenue of C$74.2M
2024-04-16+2.7%newsYahoo! Finance CanadaTSX Healthcare in April 2024: The Best Stocks to Buy Right Now - Yahoo! Finance Canada
2023-07-12+2.6%newsSeeking AlphaKnight to buy up to 5.99M common shares
2022-11-13+2.4%earningsSeeking AlphaKnight Therapeutics Inc. (KHTRF) Q3 2022 Earnings Call Transcript
2023-05-25-2.2%newsStockhouseTSX:GUD Forum Post | wofats-35862067 | From La Presse | Knight Therapeutics Inc - Stockhouse
2023-11-09+1.4%earningsSeeking AlphaKnight Therapeutics reports Q3 results
2024-02-29-1.3%expansionSeeking AlphaKnight Therapeutics launches Minjuvi in Brazil
2026-04-23+1.3%newsSimply Wall St.3 TSX Stocks That May Be Trading Below Their Estimated Value
2023-12-11-1.2%newsYahoo! Finance Canada2 Top Pharmaceutical Stocks to Buy on the TSX Today - Yahoo! Finance Canada
2025-01-27+1.1%newsYahoo! Finance CanadaGot $4,000? 4 Healthcare Stocks to Buy and Hold Forever - Yahoo! Finance Canada
2026-04-24+1.0%newsSimply Wall St.TSX Growth Companies With Strong Insider Ownership
2026-04-15-1.0%newsGlobeNewswireKnight to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
2024-05-11+0.9%earningsSeeking AlphaKnight Therapeutics, Inc. (KHTRF) Q1 2024 Earnings Call Transcript
2025-03-20+0.9%earningsSeeking AlphaKnight Therapeutics Inc. (KHTRF) Q4 2024 Earnings Call Transcript
2025-03-20+0.9%newsSeeking AlphaKnight Therapeutics reports results
2025-03-20+0.9%legalYahoo! Finance Canada3 Top Healthcare Sector Stocks for Canadian Investors in 2025 - Yahoo! Finance Canada
2022-10-11-0.9%newsYahoo FinanceKnight Therapeutics Inc. (TSE:GUD) most popular amongst individual investors who own 57%, insiders hold 20% - Yahoo Finance
2025-08-20+0.7%newsSeeking AlphaKnight Therapeutics announces share buyback plan
2025-08-08-0.6%earningsSeeking AlphaKnight Therapeutics Inc. (KHTRF) Q2 2025 Earnings Call Transcript
2025-05-08-0.6%earningsSeeking AlphaKnight Therapeutics reports Q1 results
2024-08-09-0.5%earningsSeeking AlphaKnight Therapeutics Inc. GAAP EPS of -C$0.02, revenue of C$95.57M
2024-01-25-0.4%newsSeeking AlphaAmneal Pharma inks licensing pact with Knight Therapeutics
2024-01-25-0.4%newsStreetwise ReportsPharma Co. Primed for Future Business - Streetwise Reports
2024-11-09-0.4%earningsSeeking AlphaKnight Therapeutics Inc. (KHTRF) Q3 2024 Earnings Call Transcript
2023-08-10-0.3%earningsSeeking AlphaKnight Therapeutics, Inc. (KHTRF) Q2 2023 Earnings Call Transcript
2023-08-10-0.3%earningsSeeking AlphaKnight Therapeutics GAAP EPS of C$0.02, revenue of C$89.9M
2023-05-13-0.2%earningsSeeking AlphaKnight Therapeutics Inc. (KHTRF) Q1 2023 Earnings Call Transcript
2024-05-09-0.0%earningsSeeking AlphaKnight Therapeutics reports Q1 results
2026-04-27—expansionMSNKnight Therapeutics announces launch of JORNAY PM - MSN
tickerdossier.comtickerdossier.substack.com